Invited commentary.
Burfeind
William
W
St. Luke's Health Network, 701 Ostrum St, Suite 201, Bethlehem, PA 18015, USA. burfeiw@slhn.org
D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003661:Decision Support Techniques; D004938:Esophageal Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D016629:Esophagectomy / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D015201:Meta-Analysis as Topic; D009010:Monte Carlo Method; D009361:Neoplasm Invasiveness / Q000473:pathology*; D011379:Prognosis; D011788:Quality of Life; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D016019:Survival Analysis